7/9/2021 Exposure to phosphoglycerate kinase 1 activators and incidence of Parkinson’s disease Gros P, Wang X, Guan J, Lang AE, Austin PC, Welk B, Visanji NP, Marras C. Mov Disord. 2021; Jul 9 [Epub ahead of print]. DOI: https://doi.org/10.1002/mds.28712
8/28/2020 Survival and health care use after deep brain stimulation for Parkinson’s Disease Crispo JAG, Lam M, Le B, Shariff SZ, Ansell DR, Squarzolo M, Ouellette D, Thibault DP, Marras C, Willis AW, Seitz D. Can J Neurol Sci. 2021; 48(3):372-82. Epub 2020 Aug 28. DOI: https://doi.org/10.1017/cjn.2020.187
5/15/2020 Beta agonists and progression of Parkinson’s disease in older adults a retrospective cohort study Marras C, Pequeno P, Austin PC, Gershon AS, Iqbal J, Rochon PA, Lang AE. Mov Disord. 2020; 35(7):1275-7. Epub 2020 May 15. DOI: https://doi.org/10.1002/mds.28085